본문 바로가기
KERD
논문KCI 등재

하인두암의 치료방법에서 Docetaxel과 Platinum을 이용한 선행항암화학요법의 효과분석

The Analysis of Induction Chemotherapy Using Docetaxel and Platinum in Treatment of Hypopharyngeal Carcinoma

이은정|이경석|임상호|홍기환|양윤수|황병언|유순호|하일우|김종승
대한이비인후과학회 (Korean Society of Otorhinolaryngology-Head and Neck Surgery)|2010.11|대한이비인후과학회지 두경부외과학 (Korean Journal of Otorhinolaryngology-Head and Neck Surgery)|제53권 제11호|pp. 706-711

0

조회

0

다운로드

1

인용

0

참고문헌

주제분류이비인후과학

초록

Background and Objectives The aim of this study was to determine the efficacy of induction chemotherapy with docetaxel and platinum in patients with hypopharyngeal carcinoma. Subjects and Method The medical records of 66 patients who were diagnosed with hypopharyngeal carcinoma at our department from January 1996 to December 2008 were reviewed and retrospectively analyzed. The patients were divided into four groups according to treatment method: Group I was treated with radiation and induction chemotherapy consist of docetaxel and platinum (27); Group II was treated with surgery and induction chemotherapy consist of docetaxel and platinum (28), Group III was treated with radiation and induction chemotherapy consist of 5-FU and platinum (9) and Group IV was treated with surgery and induction chemotherapy consist of 5-FU and platinum (2). A total of 186 chemotherapy cycles were administered to patients and most of the patients received at least 2 cycles. Results The T-stage distribution at diagnosis was 7.5%, 42.4%, 28.8%, and 21.2% for T1, T2, T3, and T4, respectively. The N-stage distribution at diagnosis was 48.5%, 22.7%, 10.6%, 15.2%, and 9.1% for N0, N1, N2a, N2b, and N2c, respectively. The overall 3-year survival rate was 44.3%. The 3-year survival rate of each group was 42.6% in Group I, 54.8% in Group II, and 11.1% in Group III. There was no significant difference in survival between Groups I and III (p=0.074). There was no difference in sex, age, and N stage for 3-year survival rate. Conclusion Although any valid conclusions could not be drawn because of the small number of patients examined here, induction chemotherapy consisting of docetaxel and platinum may improve the outcome of patients with hypopharyngeal carcinoma. Korean J Otorhinolaryngol-Head Neck Surg 2010;53:706-11

Abstract

Background and Objectives The aim of this study was to determine the efficacy of induction chemotherapy with docetaxel and platinum in patients with hypopharyngeal carcinoma. Subjects and Method The medical records of 66 patients who were diagnosed with hypopharyngeal carcinoma at our department from January 1996 to December 2008 were reviewed and retrospectively analyzed. The patients were divided into four groups according to treatment method: Group I was treated with radiation and induction chemotherapy consist of docetaxel and platinum (27); Group II was treated with surgery and induction chemotherapy consist of docetaxel and platinum (28), Group III was treated with radiation and induction chemotherapy consist of 5-FU and platinum (9) and Group IV was treated with surgery and induction chemotherapy consist of 5-FU and platinum (2). A total of 186 chemotherapy cycles were administered to patients and most of the patients received at least 2 cycles. Results The T-stage distribution at diagnosis was 7.5%, 42.4%, 28.8%, and 21.2% for T1, T2, T3, and T4, respectively. The N-stage distribution at diagnosis was 48.5%, 22.7%, 10.6%, 15.2%, and 9.1% for N0, N1, N2a, N2b, and N2c, respectively. The overall 3-year survival rate was 44.3%. The 3-year survival rate of each group was 42.6% in Group I, 54.8% in Group II, and 11.1% in Group III. There was no significant difference in survival between Groups I and III (p=0.074). There was no difference in sex, age, and N stage for 3-year survival rate. Conclusion Although any valid conclusions could not be drawn because of the small number of patients examined here, induction chemotherapy consisting of docetaxel and platinum may improve the outcome of patients with hypopharyngeal carcinoma. Korean J Otorhinolaryngol-Head Neck Surg 2010;53:706-11

참고문헌 (19)

  1. 태경, "하인두암의 치료성적: 수술 또는 기관보존요법", 대한이비인후과학회지 두경부외과학, 52(8), pp.688~694 (2009), 대한이비인후과학회
  2. Gourin CG, "Carcinoma of the hypopharynx", Surg Oncol Clin N Am, 13(1), pp.81~98 (2004)
  3. 전경명, "Cisplatin에 내성을 가지는 두경부 세포주에서 Docetaxel의 교차내성에 관한 연구", 대한이비인후과학회지 두경부외과학, 48(5), pp.651~655 (2005), 대한이비인후과학회
  4. Colevas AD, "Phase I-II trial of outpatient docetaxel, cisplatin, 5-fluorouracil, leucovorin (op TPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)", Am J Clin Oncol, 25(2), pp.153~159 (2002)
  5. Lefebvre JL, "Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group", J Natl Cancer Inst, 88(13), pp.890~899 (1996)
  6. Kim KH, "Neoadjvant chemotherapy and radiotherapy for the treatment of advanced hypopharyngeal carcinoma", Korean J Otolaryngol-Head Neck Surg, 40(3), pp.429~434 (1997)
  7. 왕수건, "하인두암에서 선행항암화학요법 후 방사선치료의 의의", 대한이비인후과학회지 두경부외과학, 46(12), pp.1058~1063 (2003), 대한이비인후과학회
  8. Okamoto M, "Clinical impact of using chemoradiotherapy as a primary treatment for hypopharyngeal cancer", Acta Otolaryngol Suppl, 547, pp.11~14 (2002)
  9. Urba SG, "Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncolocy Group Trial", J Clin Oncol, 23(1), pp.88~95 (2005)
  10. Kish J, "Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of head and neck", Cancer Treat Rep, 66(3), pp.471~474 (1982)
  11. Yeo W, "A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma", Eur J Cancer, 34(13), pp.2027~2031 (1998)
  12. Janinis J, "Sequential chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced head and neck cancer", Am J Clin Oncol, 24(3), pp.227~231 (2001)
  13. Posner MR, "Multicenter phase I-II trial of do-cetaxel, cisplatin and fluorouracil induction chemotherapy for patients with locally advanced squamous cell carcinoma of the head and neck", J Clin Oncol, 19(4), pp.1096~1104 (2001)
  14. Cooper JS, "Concurrent chemotherapy and radiation therapy for advanced stage carcinoma of the nasopharynx", Int J Radiat Oncol Biol Phys, 48(5), pp.1277~1279 (2000)
  15. Catimel G, "Docetaxel (Taxotere): an active drug for the treatment of pa-tients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group", Ann Oncol, 5(6), pp.533~537 (1994)
  16. Schöffski P, "Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group", Ann Oncol, 10(1), pp.119~122 (1999)
  17. Forastier AA, "Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck", Semin Oncol, 20(4), pp.56~60 (1993)
  18. 백승재, "비인강암의 치료 성적과 예후인자 및 치료 실패의 분석", 대한이비인후과학회지 두경부외과학, 48(10), pp.1254~1260 (2005), 대한이비인후과학회
  19. Jung Hyun Lee, "Docetaxel and Cisplatin Combination Chemotherapy in Patients with Squamous Cell Carcinomas of the Head and Neck", Cancer Research and Treatment, 35(3), pp.261~266 (2003), 대한암학회

관련 논문AI추천

비인강암의 치료방법에서 Docetaxel과 Platinum을 이용한 유도항암요법의 효과공일승, 권삼현, 양윤수, 최동일, 홍기환대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2008 · 제51권 제1호진행성 두경부암의 Docetaxel과 Cisplatin의 항암화학요법의 치료효과김용대, 배창훈, 송시연, 최성원, 최영호영남대학교 의과대학 · Journal of Yeungnam Medical Science2006 · 제23권 제2호하인두암의 치료성적: 수술 또는 기관보존요법태경, 김태헌, 신광수, 신지훈, 안태환, 이명자, 전하정, 정진혁대한이비인후과학회 · 대한이비인후과학회지 두경부외과학2009 · 제52권 제8호The Efficacy of an Induction Chemotherapy Combination with Docetaxel, Cisplatin, and 5-FU Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Cancer김여경, 김형준, 양덕환, 이제중, 이준규, 임상철, 정웅기, 정익주, 조상희, Jae-Sook Ahn, Ok-Ki Kim대한암학회 · Cancer Research and Treatment2007 · 제39권 제3호Induction Chemotherapy of Docetaxel and Cisplatin for the Elderly Patients with Squamous Cell Carcinoma of the Head and Neck김동원, 김학진, 손창학, 신호진, 왕수건, 이병주, 이원식, 정주섭, 조병만, 주영돈, 최영진, Goon-Jae Cho대한암학회 · Cancer Research and Treatment2007 · 제39권 제1호Analysis of the Prognostic Factors for Distant Metastasis after Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Head and Neck Cancer기용간, 김동원, 김동현, 김원택, 남지호, 설영미, 이병주, 이주혜, 이진춘, 최영진대한암학회 · Cancer Research and Treatment2015 · 제47권 제1호

이 간행물의 다른 논문 (8건)

상기도 감염에 의한 후각 장애배우용pp. 669-674사람 상피세포주(HaCaT)에서의 간극결합 세포 간 신호전달의 조절강희선, 김병철, 강성욱, 전형진, 홍정주, 정연훈pp. 675-685구강을 통한 몰입형 하마종의 수술적 치료박희택, 이경석, 임상호, 홍기환, 양윤수, 황병언, 유순호pp. 702-705하비갑개에서 발생한 점액표피양암종 1예정영준, 김영훈, 정상환, 조일권pp. 712-715부갑상선기능항진증으로 발생한 하악골 갈색종 1예한두희, 이철희, 김민수pp. 716-718
원문 보기